Skip to Content

Join the 'Breast Cancer - Adjuvant' group to help and get support from people like you.

Breast Cancer - Adjuvant News

Risk of Breast Cancer's Return Can Linger for Decades

Posted 12 days ago by Drugs.com

WEDNESDAY, Nov. 8, 2017 – Women treated for early stage breast cancer still face a substantial risk of recurrence up to 20 years later, a large, new study shows. Cancer experts say the findings should help inform women's treatment decisions. Specifically, the researchers followed women with estrogen-receptor-positive breast cancer, which means the hormone helps fuel the cancer's growth. Standard treatment includes hormonal therapy – with drugs that block estrogen's effects – to help prevent a return of the cancer. All of the women in the study, nearly 63,000, were scheduled to receive the typical five years of hormonal therapy. Researchers found that while the women remained cancer-free for those five years, the risk for recurrence over the next 15 years was still significant. It was greatest for women whose initial cancer had spread to multiple lymph nodes near the breast by the ... Read more

Related support groups: Cancer, Breast Cancer, Tamoxifen, Arimidex, Anastrozole, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer, Tamoxifen Hexal, Nolvadex, Soltamox, Tamone, Tamoxen, Genox, Nolvadex D, Tamofen, Tamosin, Emblon

Why Many Breast Cancer Patients Short-Circuit Their Treatment

Posted 14 days ago by Drugs.com

MONDAY, Nov. 6, 2017 – Many breast cancer patients skip recommended treatment after surgery because they lack faith in the health care system, a new study indicates. A patient survey found those who reported a general distrust of medical institutions and insurers were more likely to forgo follow-up breast cancer treatment, such as chemotherapy, hormone therapy or radiation. Trust or distrust of their own doctors did not emerge as a factor. "If we want more women with breast cancer to complete their treatment, we'll need to deal with their beliefs about the health care system – and I do think we can modify those beliefs," said study lead author Lorraine Dean. She's an assistant professor of epidemiology at Johns Hopkins University. Dean's team surveyed more than 2,700 patients in Florida and Pennsylvania after breast cancer surgery. More than 30 percent disregarded their doctor's ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer

Even Advanced Breast Cancer Patients Gain From Exercise

Posted 18 days ago by Drugs.com

THURSDAY, Nov. 2, 2017 – For women with advanced breast cancer, a well-planned exercise program might have a big impact on their quality of life, a small study suggests. Though cancer treatment can extend the lives of women with advanced breast cancer, many patients experience pain, fatigue and a reduced ability to carry out normal daily activities. The study involved 15 women, aged 34 to 68, who were undergoing treatment for advanced breast cancer and were not exercising. Seven continued to receive normal care, and eight were assigned to a 12-week exercise program that included an hour of exercise twice a week, including aerobic and resistance training. Compared with those in the normal-care group, women who exercised showed significant improvements in heart health, pain, fatigue, emotional well-being and the ability to do daily tasks. "This is a small group of patients, but the ... Read more

Related support groups: Fatigue, Breast Cancer, Breast Cancer - Adjuvant, Prevention of Cardiovascular Disease, Breast Cancer, Prevention, Cardiovascular Risk Reduction, Breast Cancer - Palliative

Many High-Risk Women Skip MRI Breast Cancer Screenings

Posted 26 Oct 2017 by Drugs.com

THURSDAY, Oct. 26, 2017 – Knowing they're at increased risk for breast cancer isn't enough to persuade many women to get MRI screenings – even if they're free. Researchers studied more than 1,000 women in a U.S. military health system who had a 20 percent or greater lifetime risk of breast cancer due to genetics or personal or family history. Between 2015 and 2016, they were offered free MRI cancer screening at the Madigan Army Medical Center in Tacoma, Wash. (Women with higher than average risk are advised to start annual MRIs and mammograms at age 30, according to the American Cancer Society.) But only 23 percent of the women underwent MRI screening. That included 15 percent of those with a 20 to 24 percent lifetime risk of breast cancer, and only half of those with more than a 40 percent risk. The study was to be presented Wednesday at an American College of Surgeons meeting in San ... Read more

Related support groups: Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Diagnosis and Investigation, Body Imaging

Joan Lunden's Breast Cancer Journey: 'You Feel So Vulnerable'

Posted 26 Oct 2017 by Drugs.com

THURSDAY, Oct. 26, 2017 – Joan Lunden – co-host of "Good Morning America" for nearly two decades and a long-time health advocate – is now also a breast cancer survivor. By sharing her experience, Lunden hopes she can help other women facing a frightening cancer diagnosis. "It's so shocking when you hear you have cancer, and you feel so vulnerable," said Lunden, 67. Lunden never missed an annual mammogram to check for breast cancer. But each year, she said the process was "nerve-racking" because she has dense breast tissue that can make it difficult to distinguish healthy breast tissue from tumor tissue. Many women with dense breast tissue, particularly those with risk factors for breast cancer such as a family history, are advised to get additional testing – an MRI or sometimes an ultrasound. When Lunden went in for an ultrasound, she received shocking news. "I had an aggressive, ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Diagnosis and Investigation, Body Imaging

Textured Breast Implants Linked to Rare Cancer

Posted 20 Oct 2017 by Drugs.com

FRIDAY, Oct. 20, 2017 – A particular breast implant may be associated with a rare type of cancer, researchers report. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is estimated to affect 1 in 30,000 women each year, but researchers said it may actually be more common. "We're seeing that this cancer is likely very underreported, and as more information on this type of cancer comes to light, the number of cases is likely to increase in the coming years," said Dr. Dino Ravnic. He is an assistant professor of surgery at Penn State College of Medicine. Penn State investigators reviewed 115 research reports in which 95 patients were evaluated to learn more about risk, development and treatment of BIA-ALCL. Nearly all cases were associated with textured breast implants, which have a slightly rough surface to keep them in the correct position. "We're still exploring the ... Read more

Related support groups: Surgery, Breast Cancer, Lymphoma, Breast Cancer - Adjuvant, Breast Cancer, Prevention

Breast Cancer More Lethal for Blacks Than Whites

Posted 16 Oct 2017 by Drugs.com

MONDAY, Oct. 16, 2017 – Differences in insurance are a major reason why black women are more likely to die of breast cancer than white women in the United States, a new study contends. "We found that differences in insurance explained one-third of the total excess risk of death in non-elderly black women compared to white women diagnosed with early stage breast cancer, while differences in tumor characteristics explained approximately one-fifth of the excess risk," lead study author Ahmedin Jemal, of the American Cancer Society (ACS), and colleagues wrote. In 2014, breast cancer death rates were 41 percent higher among black women than among white women in the United States, the researchers said. To learn more about this disparity, the investigators looked at information on more than 550,000 non-elderly women with early stage breast cancer. Black women were more likely to be uninsured ... Read more

Related support groups: Depo-Provera, Provera, Breast Cancer, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Lupron Depot, Femara, Anastrozole, Breast Cancer, Metastatic, Letrozole, Zoladex, Evista, Megace, Megestrol, Aromasin, Breast Cancer - Adjuvant, Casodex, Exemestane

More Women Choose Breast Reconstruction After Mastectomy

Posted 13 Oct 2017 by Drugs.com

FRIDAY, Oct. 13, 2017 – Over five years, the proportion of U.S. breast cancer patients opting for breast reconstruction after mastectomy grew by about two-thirds, a new government report shows. An analysis of patient data shows breast reconstruction followed 40 percent of breast-removal surgeries in 2014 – up from less than one-quarter in 2009, according to the U.S. Agency for Healthcare Research and Quality (AHRQ). Among age groups, women aged 65 and older accounted for the largest increase in breast reconstructive surgery – 140 percent. "This type of information is essential for policymakers and health systems seeking to keep pace with important trends in clinical care," Gopal Khanna, agency director, said in an AHRQ news release. The overall increase during the study period was 65 percent, researchers said. While reconstruction procedures increased in all insurance groups, the ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative

Need Cancer Screening? Where You Work Matters

Posted 13 Oct 2017 by Drugs.com

FRIDAY, Oct. 13, 2017 – Waiters, contractors and other employees of America's small businesses are more likely to miss out on cancer screening, mostly because of a lack of insurance, new research shows. "Workers employed at smaller organizations had substantially lower breast, cervical and colorectal cancer screening rates" compared to people working at larger corporations or organizations, American Cancer Society (ACS) researchers reported. And poorer insurance coverage accounted for much of these differences, said the team led by ACS researcher Stacey Fedewa. One breast cancer specialist who reviewed the findings said the issue is an important one, because mammograms, colonoscopies and other screens can save lives – not to mention health care dollars. So it's crucial to "find ways to ensure that workers in smaller companies have access to health care," said Dr. Stephanie Bernik, ... Read more

Related support groups: Cancer, Breast Cancer, Colonoscopy, Colorectal Cancer, Breast Cancer - Adjuvant, Cervical Cancer, Breast Cancer, Prevention

Double Mastectomy Increases Time Spent Off Work

Posted 9 Oct 2017 by Drugs.com

MONDAY, Oct. 9, 2017 – Working women who choose an aggressive treatment for breast cancer are likely to miss a significant amount of time before returning to the job. That's the conclusion of a study that focused on approximately 1,000 women in Georgia and Los Angeles who had to decide between various options for dealing with their cancer diagnosis. More than 60 percent of the women, aged 20 to 79, chose a lumpectomy, a relatively less aggressive intervention. One-third chose chemotherapy, while 16 percent had one breast removed (a unilateral mastectomy), the study authors said. Another 23 percent had both breasts removed (a bilateral mastectomy), which is considered the most aggressive option. Nearly 85 percent of the women had been working full-time prior to their diagnosis. Those who chose a bilateral mastectomy with breast reconstruction were eight times more likely to miss over a ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative

Mastectomy Study Confirms 'Jolie Effect'

Posted 25 Sep 2017 by Drugs.com

MONDAY, Sept. 25, 2017 – Actress Angelina Jolie's decision to undergo breast removal to reduce her risk of breast cancer has led other women to do so, a new study shows. The findings show that celebrities can influence the health care decisions of the general public, said study author Art Sedrakyan, a professor at Weill Cornell Medicine in New York City. In early 2013, Jolie announced her decision to have the preventive surgery to have both breasts removed due to her elevated genetic risk for breast cancer. Researchers sought to determine the impact of that news by analyzing 2004-2014 data on risk-reducing mastectomy in New York State and New South Wales in Australia. In New York, they found the number of women undergoing the procedure nearly doubled – rising from 3.3 bimonthly cases per 1 million 20 months before Jolie's announcement to 6.3 cases per 1 million 20 months after her ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer

Breast Cancer Radiation 'Less Scary' Than Thought

Posted 25 Sep 2017 by Drugs.com

MONDAY, Sept. 25, 2017 – Radiation therapy for breast cancer is actually "less scary" than anticipated, nine out of 10 patients say after treatment. A survey of 300-plus breast cancer patients also found that more than 80 percent said the side effects of radiation were better than expected. "The word radiation itself sounds frightening and is associated with many negative news stories," said lead researcher Dr. Narek Shaverdian, of the University of California, Los Angeles (UCLA). But over the last 20 years, significant advances have been made, said Shaverdian, chief resident in radiation oncology at UCLA's David Geffen School of Medicine. "These changes allow us to spare critical organs, create an individual radiation plan for each patient, and also deliver radiation in more convenient schedules," he explained. Shaverdian and his team surveyed patients who had received radiation while ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Nausea/Vomiting - Radiation Induced, Osteolytic Bone Metastases of Breast Cancer, History - Radiation Therapy

Surgeons Play Big Role in Women's Choices for Breast Cancer Care

Posted 13 Sep 2017 by Drugs.com

WEDNESDAY, Sept. 13, 2017 – A breast cancer patient's choice of surgeon can have a major effect on her treatment, according to a new study. That's because surgeons have a strong influence on whether early stage cancer patients have both breasts removed even when cancer is found in only one breast – a procedure called contralateral prophylactic mastectomy (CPM). Researchers surveyed more than 3,300 women with early stage breast cancer and 349 surgeons who treated them. About 16 percent of the patients had both breasts removed. Only 4 percent of those whose surgeons heavily favored breast-saving surgery and were most reluctant to remove both breasts had the procedure. That compared to 34 percent of patients whose surgeons were most willing to do the surgery, the study found. "That difference is huge. Even for a procedure that is very patient-driven, we see that surgeons account for a ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Surgical Prophylaxis

Breast Cancer Patients On Opioid Treatment More Likely To Discontinue Hormones

Posted 11 Sep 2017 by Drugs.com

MONDAY, Sept. 11, 2017 – Breast cancer patients who take opioid painkillers are more likely to discontinue an important hormone treatment that helps ensure their survival, researchers report. Use of prescription opioids such as OxyContin (oxycodone) and Vicoprofen (hydrocodone) was "significantly associated" with failure to adhere to the hormone therapy and a higher risk of death, the study found. "It's not a big secret that the U.S. uses more opioids than any other country in the world," said researcher Rajesh Balkrishnan, of the University of Virginia School of Medicine's department of public health sciences. "Clearly there has to be better management of opioids in the elderly cancer population," Balkrishnan said in a university news release. For the study, researchers analyzed follow-through rates for adjuvant endocrine therapy – commonly called hormone treatment – among more than ... Read more

Related support groups: OxyContin, Breast Cancer, Tamoxifen, Arimidex, Anastrozole, Breast Cancer, Metastatic, Vicoprofen, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Tamoxifen Hexal, Nolvadex, Tamofen, Tamosin, Genox, Nolvadex D, Soltamox, Tamone, Emblon, Tamoxen

'Cancer Pen' Could Help Surgeons Spot Tumor Cells in Seconds

Posted 6 Sep 2017 by Drugs.com

WEDNESDAY, Sept. 6, 2017 – A new "cancer pen" promises to help surgeons immediately detect and completely remove cancerous tumor tissue, without having to send samples off to a lab for testing while the patient languishes on the table. The MasSpec Pen is a hand-held device that allows doctors to test in real-time whether tissue is cancerous or not, delivering results in about 10 seconds, researchers report. The pen will make it easier to surgically clear out all the cancer cells surrounding a tumor, explained senior researcher Livia Eberlin, an assistant professor of chemistry with the University of Texas at Austin. In particular, cancers such as those of the breast, pancreas and brain "tend to invade surrounding normal tissue," Eberlin said. "For a surgeon, it can be really tricky, because these cells resemble normal tissue. Just judging by [the] eye, it can be very challenging." The ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Brain Tumor, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Diagnosis and Investigation

Page 1 2 3 4 5 6 7 8 9 10 Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer

Related Drug Support Groups

tamoxifen, Femara, letrozole, Herceptin, Taxol, paclitaxel, epirubicin, leuprolide, Nerlynx, view more... trastuzumab, Nolvadex, Tamoxifen Hexal, Genox, Pharmorubicin RDF, Pharmorubicin PFS, Tamosin, Tamoxen, Ellence, Nolvadex D, neratinib, Emblon, Tamone, Soltamox, Onxol, Tamofen